Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease

被引:11
|
作者
Wu, Weiti [1 ]
Xiang, Jingjing [2 ]
Chen, Xiaoye [3 ]
机构
[1] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China
[2] Taizhou Hosp, Dept Emergency, Taizhou, Zhejiang, Peoples R China
[3] Taizhou Hosp, Dept Radiotherapy, Taizhou, Zhejiang, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
non-alcoholic fatty liver disease; diabetes mellitus; NHANES; cardiovascular; mortality; HEPATIC INSULIN-RESISTANCE; NAFLD; RISK; PATHOGENESIS; MEN;
D O I
10.3389/fendo.2021.773342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThe influence of diabetes on mortality among patients with non-alcoholic fatty liver disease (NAFLD) in the general population has not been extensively studied. This study aimed to determine the relationship between diabetes and all-cause and cardiovascular mortality in patients with hepatic ultrasound-confirmed NAFLD using data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. MethodsData from 4,037 adult individuals with NAFLD from the NHANES III and mortality outcomes linked to National Death Index records through December 31, 2015, were included. Cox proportional hazards models were used to calculate the hazard ratio (HR) and corresponding 95% CI for mortality from all causes and cardiovascular disease after adjusting for multiple variables. ResultsAmong 4,037 subjects with NAFLD (55.9% female), 483 had diabetes at baseline. During a median follow-up of 22.1 years, 1,517 (11.5%) died, including 332 (8.22%) from cardiovascular causes. Diabetes was associated with increased all-cause (HR 3.02 [95% CI 2.67-3.41]) and cardiovascular (HR 3.36 [95% CI 2.61-4.32]) mortality in an unadjusted multivariable Cox regression model. The association remained statistically significant after adjusting for a range of potential confounders (HR 2.20 [95% CI 1.90-2.55] for all-cause mortality and HR 2.47 [95% CI 1.81-3.37] for cardiovascular mortality). An additional stratified analysis did not reveal significantly altered results. ConclusionDiabetes was associated with all-cause and cardiovascular mortality in patients with NAFLD. This link could be further characterized in future studies assessing the degree of glycemic control and its relationship with mortality in patients with diabetes and NAFLD.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Muscle strength in non-alcoholic fatty liver disease and all-cause and cause-specific mortality
    Kim, Donghee
    Dennis, Brittany B.
    Wijarnpreecha, Karn
    Cholankeril, George
    Ahmed, Aijaz
    LIVER INTERNATIONAL, 2023, 43 (02) : 513 - 516
  • [12] Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients A systematic review and meta-analysis
    Saokaew, Surasak
    Kanchanasurakit, Sukrit
    Thawichai, Kanitta
    Duangprom, Prommanee
    Wannasri, Monnapha
    Khankham, Sirintip
    Kositamongkol, Chayanis
    Chaiyakunapruk, Nathorn
    Phisalprapa, Pochamana
    MEDICINE, 2021, 100 (05) : E24557
  • [13] Liver stiffness (Fibroscan®) is a predictor of all-cause mortality in people with non-alcoholic fatty liver disease
    Braude, Michael
    Roberts, Stuart
    Majeed, Ammar
    Lubel, John
    Prompen, Jirayut
    Dev, Anouk
    Sievert, William
    Bloom, Stephen
    Gow, Paul
    Kemp, William
    LIVER INTERNATIONAL, 2023, 43 (01) : 90 - 99
  • [14] Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Stepanova, Maria
    Rafiq, Nila
    Makhlouf, Hala
    Agrawal, Ritambhara
    Kaur, Ishmeet
    Younoszai, Zahra
    McCullough, Arthur
    Goodman, Zachary
    Younossi, Zobair M.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (10) : 3017 - 3023
  • [15] Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Maria Stepanova
    Nila Rafiq
    Hala Makhlouf
    Ritambhara Agrawal
    Ishmeet Kaur
    Zahra Younoszai
    Arthur McCullough
    Zachary Goodman
    Zobair M. Younossi
    Digestive Diseases and Sciences, 2013, 58 : 3017 - 3023
  • [16] Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
    Padda, Jaskamal
    Khalid, Khizer
    Khedr, Anwar
    Tasnim, Fahriba
    Al-Ewaidat, Ola A.
    Cooper, Ayden Charlene
    Jean-Charles, Gutteridge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [17] Association of Nonalcoholic Fatty Liver Disease and Liver Fibrosis with Cardiovascular Disease, All-Cause, and Cause-Specific Mortality in Individuals with Type 2 Diabetes
    Xu, Shaoyong
    You, Qiqi
    Liu, Longfu
    DIABETES, 2024, 73
  • [18] Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors
    Mann, Jake P.
    Carter, Paul
    Armstrong, Matthew J.
    Abdelaziz, Hesham K.
    Uppal, Hardeep
    Patel, Billal
    Chandran, Suresh
    More, Ranjit
    Newsome, Philip N.
    Potluri, Rahul
    PLOS ONE, 2020, 15 (10):
  • [19] Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
    Khneizer, Gebran
    Rizvi, Syed
    Gawrieh, Samer
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 417 - 440
  • [20] Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
    Kim, Kyung-Soo
    Hong, Sangmo
    Han, Kyungdo
    Park, Cheol-Young
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 384